Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Teva v Pfizer: Creating an Uncertain Future for Generics Companies by De-Modernising the Medicare Modernization Act

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online July, 2005

Teva v Pfizer: Creating an Uncertain Future for Generics Companies by De-Modernising the Medicare Modernization Act

and

Volume 2, Issue 4

https://doi.org/10.1057/palgrave.jgm.4940088

Abstract

Keywords

declaratory judgment Medicare Modernization Act patent certainty Abbreviated New Drug Application ANDA.

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Pharmaceutical Pricing and Hatch–Waxman Reform: The Right Prescription

Retricted access

A Novel Development and Portfolio Management Strategy for Generic Small Molecule Drug Products: Watergile ANDA

Retricted access

Generic entry and effect of market competition on outpatient pharmacy drug prices

Retricted access

US FDA Question-Based Review for Generic Drugs: A New Pharmaceutical Quality Assessment System